Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001968582-24-001180
Filing Date
2024-12-13
Accepted
2024-12-13 16:08:54
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3959
  Complete submission text file 0001968582-24-001180.txt   5696
Mailing Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 617-744-1340
Syros Pharmaceuticals, Inc. (Subject) CIK: 0001556263 (see all company filings)

EIN.: 453772460 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-37813 | Film No.: 241548409
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 55 CAMBRIDGE PARKWAY, 8TH FLOOR CAMBRIDGE MA 02142
Business Address 55 CAMBRIDGE PARKWAY, 8TH FLOOR CAMBRIDGE MA 02142 617-868-1888
Flagship Ventures Fund IV-Rx, L.P. (Reporting) CIK: 0001590973 (see all company filings)

EIN.: 453977297 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144